Kairos Pharma Growth Metrics (2024-2025) | KAPA

Growth Metrics Jun2024 Sep2024 Dec2024 Mar2025 Jun2025
Growth Ratios
Assets (QoQ) 15.27%37.60%-15.93%
Cash & Equivalents (QoQ) -16.10%
Cash from Operations Growth (1y) -2,083.33%-379.17%
Cash from Operations (QoQ) -566.67%-1,102.38%10.74%60.40%-12.75%
EBITDA Margin Growth (1y) -179502.00
EBITDA Margin (QoQ) 5,625.00-177868.00
EBIT Growth (1y) -341.11%-555.86%
EBIT Margin Growth (1y) -179502.00
EBIT Margin (QoQ) 5,625.00-177868.00
EBIT (QoQ) 22.65%-72.52%-277.55%12.45%-15.01%
EBT Growth (1y) -316.50%-507.69%
EBT Margin Growth (1y) -189501.00
EBT Margin (QoQ) 5,625.00-177868.00
EBT (QoQ) 22.77%-293.16%-71.63%20.08%-12.68%
Enterprise Value (QoQ) 16.10%
EPS (Basic) Growth (1y) -166.67%-300.00%
EPS (Basic) (QoQ) 33.33%-321.62%-64.89%42.46%0.00%
EPS (Weighted Average and Diluted) Growth (1y) -166.67%-300.00%
EPS (Weighted Average and Diluted) (QoQ) 33.33%-321.62%-64.89%42.46%0.00%
FCF Margin Growth (1y) 22,429.00
FCF Margin (QoQ) 162,500.00-102384.00
Free Cash Flow Growth (1y) -2,083.33%-379.17%
Free Cash Flow (QoQ) -566.67%-1,102.38%10.74%60.40%-12.75%
Interest Coverage Ratio (QoQ) -3.14%96.14%-1,424.38%
Net Cash Flow Growth (1y) 4,522.64%-2,963.16%
Net Cash Flow (QoQ) 64.15%16,921.05%-160.86%220.51%-124.83%
Net Income Growth (1y) -316.50%-507.69%
Net Income (QoQ) 22.77%-293.16%-71.63%20.08%-12.68%
Net Income towards Common Stockholders Growth (1y) -316.50%-507.69%
Net Income towards Common Stockholders (QoQ) 22.77%-293.16%-71.63%20.08%-12.68%
Net Margin Growth (1y) -189501.00
Net Margin (QoQ) 5,625.00-177868.00
Operating Income Growth (1y) -341.11%-555.86%
Operating Income (QoQ) 22.65%-72.52%-277.55%12.45%-15.01%
Operating Margin Growth (1y) -179502.00
Operating Margin (QoQ) 5,625.00-177868.00
Profit After Tax Growth (1y) -290.71%-462.06%
Profit After Tax (QoQ) 21.67%-313.83%6.40%-28.78%-12.68%
Return on Assets (QoQ) -2.00-13.00
Return on Capital Employed (QoQ) -2.00-14.00
Return on Equity (QoQ) 8.00-12.00
Return on Sales Growth (1y) -1895.00-1955.00
Return on Sales (QoQ) 56.00-1779.00366.00-539.00-4.00
Revenue Growth (1y) 625,100.00%
Revenue (QoQ) 25.00%-4,375.00%
Shareholder's Equity (QoQ) 43.34%49.33%-15.91%